Current status of COVID‐19 among hemodialysis patients in the East Azerbaijan Province of Iran

Khosroshahi, Hamid Tayebi; Mardomi, Alireza; Niknafs, Bahram; Farnood, Farahnoosh; Shekarchi, Mohsen; Salehi, Shabnam; Haggi, Taghi Fadaei

doi:10.1111/hdi.12907

Cited by 8 publications

(13 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In research articles reporting clinical manifestation and outcome of COVID-19 patients (78[54.4%]) the diagnosis of SARS-CoV-2 infection relied principally on RT-PCR (52[63.4%]) [ 11 – 20 , 32 , 61 , 62 , 69 , 93 , 94 , 100 , 108 – 111 , 113 , 115 – 124 , 126 , 129 , 132 , 134 , 135 , 138 – 151 ], serology (4[6.3%]) [ 18 , 20 , 22 – 24 , 86 , 99 ], RT-PCR and serological assay (5[6.6%])[ 29 – 31 , 85 , 127 , 152 ] or a combination of diagnostic tests including clinical evaluation [ 6 , 13 , 19 , 21 , 112 , 114 , 125 , 128 , 130 , 131 , 133 , 136 , 137 , 153 , 154 ].…”

Section: Resultsmentioning

confidence: 99%

“…Age of confirmed COVID-19 patients on HD was largely heterogeneous since principally tends to reflect national policy of access to dialysis treatment. Median and mean age of this large cohort of patients ranged between 48 and 79.5 years [11,15,17,21,23,61,82,94,[108][109][110][111][112][113][114][115][116][117][118][119][120][121][122] and 54.1-76 years, [6,19,25,31,32,69,93,[123][124][125][126][127][128][129][130][131][132][133][134][135] respectively. The percentage of male was 37.5%-100% of the examined population [11,13,15,17,19,…”

Section: Demographic and Clinical Characteristics Of The Confirmed Covid-19 Hd Patientsmentioning

confidence: 99%

See 1 more Smart Citation

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

et al. 2021

View full text Add to dashboard Cite

Background Patients undergoing in-centre haemodialysis (HD) are particularly exposed to the dire consequences of COVID-19. The present systematic scoping review aims to identify the extent, range, and nature of articles related to COVID-19 and maintenance HD: it reports specifically the prevalence of the COVID-19 pandemic in the HD population, implementation of strategies for the prevention, mitigation and containment of the COVID-19 pandemic in HD centres, demographic and clinical characteristics, and outcomes of the pediatric and adult HD patients. Methods A multi-step systematic search of the literature in Pubmed, Scopus, Ovid Medline, Embase and Web of Science, published between December 1, 2019, and January 30, 2021 was performed. Two authors separately screened the titles and abstracts of the documents and ruled out irrelevant articles. A report of the papers that met inclusion criteria was performed; then, a descriptive analysis of the characteristics of the included articles and a narrative synthesis of the results were performed. Results The review process ended with the inclusion of 145 articles. Most of them were based on single-centre experiences, which spontaneously developed best practices. Most studies were conducted in high-income countries (69.7%) and a part of them (9.6%) were not in English. Prevalence of COVID-19 among dialysis patients accounted for 0%-37.6%. Preventive measures were reported in 54% of the included articles, with particular emphasis on education, triage, hygiene, and containment measures. Patients experienced a heterogeneous spectrum of symptoms that led 35%-88.2% of them to hospital admission. Median and mean hospital length of stay ranged from 8 to 28.5 and 16.2 to 22 days, respectively. Admission to intensive care units varied widely across studies (from 2.6% to 70.5%) and was associated with high mortality (42.8%-100%). Overall, prognosis was poor in 0%-47% of the hospitalized patients. Conclusions This systematic scoping review provides an overview of the current knowledge on the impact of COVID-19 on the frail world of HD patients. Furthermore, it may help to implement the existing strategies of COVID-19 prevention and provide a list of unmet needs (safe transport, testing, shelter). Finally, it may be a stimulus for performing systematic reviews and meta-analyses which will form the basis for evidence-based guidelines.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Demographic and Clinical Characteristics Of The Confirmed Covid-19 Hd Patientsmentioning

confidence: 99%

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…( 6 , 7 , 8 , 10 , 13 , 14 , 15 ) Centres in India, Iran, South Africa, and Turkey have reported SARS-CoV-2 infection rates between 7 - 47% amongst their dialysis patients, with fatality rates of 2 – 38%. ( 3 , 4 , 5 , 11 , 12 , 24 ) While infection rates in LMICs were generally higher than in HICs, differences may reflect the community infection burden at that time rather than within centre transmission,( 6 , 8 , 25 , 26 ) although outbreaks within centres have been reported globally. ( 6 , 7 ) Centre layout, including available side rooms for isolation, and patient factors have also been associated with the risk of infection.…”

Section: Discussionmentioning

confidence: 99%

“…( 2 ) The incidence of SARS-CoV-2 infection has been reported to vary from 1.0 – 19.9% of the dialysis population, with case fatality reported to range from 0 – 30.5%. ( 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 )…”

Section: Introductionmentioning

confidence: 99%

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey

Aylward

Bieber

Guedes

et al. 2022

Kidney International Reports

View full text Add to dashboard Cite

Introduction To assess the impact of the COVID-19 pandemic impact on haemodialysis centres, The Dialysis Outcomes and Practice Patterns Study and International Society of Nephrology (ISN) collaborated on a web-survey of centres. Methods A combined approach of random sampling and open invitation was used between March 2020 and March 2021. Responses were obtained from 412 centres in 78 countries and all 10 ISN regions. Results In 8 regions, rates of SARS-CoV-2 infection were <20% in most centres, but in North East Asia and Newly Independent States and Russia rates were ≥20% and ≥30%, respectively. Mortality was ≥10% in most centres in 8 regions, though lower in North America and Caribbean and North East Asia. Diagnostic testing was not available in 33%, 37%, and 61% of centres in Latin America, Africa, and East and Central Europe, respectively. Surgical masks were widely available, but severe shortages of particulate-air filter masks were reported in Latin America (18%) and Africa (30%). Rates of infection in staff ranged from 0% in 90% of centres in North East Asia to ≥50% in 63% of centres in the Middle East and 68% of centres in Newly Independent States and Russia. In most centres <10% of staff died, but in Africa and South Asia 2% and 6% of centres reported ≥50% mortality, respectively. Conclusion There has been wide global variation in SARS-CoV-2 infection rates amongst haemodialysis patients and staff, PPE availability, and testing, and the ways in which services have been redesigned in response to the pandemic.

show abstract

“…Furthermore, these patients present a higher amount of proinflammatory cytokines in their peripheral blood, which is accompanied by an increased expression of Tolllike receptors in monocytes and granulocytes, resulting in increased inflammation and tissue dysfunction. In addition to this, there exist comorbidities and "logistic" exposures because these patients need to visit haemodialysis centers 3-4 times per week which increases the vulnerability of this patient group [4,5].…”

Section: Introductionmentioning

confidence: 99%

Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2

Aroca¹,

SA²,

Vélez-Verbel³

et al. 2021

Int J Nephrol Kidney Fail

View full text Add to dashboard Cite

Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.

show abstract

Current status of COVID‐19 among hemodialysis patients in the East Azerbaijan Province of Iran

Cited by 8 publications

References 32 publications

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey

Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2

Contact Info

Product

Resources

About